Recorded March 4, 2023. This transcript has been edited for clarity.
Ileana L. Piña, MD, MPH: Hello. This is Ileana Piña. I'm at Thomas Jefferson University, and this is my blog.
I am thrilled today to have one of my good friends here with me, Dr Adam DeVore, who's the director of transplant at Duke University. There's been conversation about heart donations, and as most of you know, the hearts are not sitting on the shelf.
When our patients are sick, we really struggle — sometimes for months and maybe even years — to get a heart that is suitable for them, that is the right match, that has the right everything. Hence, many of these patients will die and others will need some kind of circulatory support.
Adam, you have presented on donation after circulatory death (DCD). Define that for us.
Adam D. DeVore, MD, MHS: In the field of heart transplant, DCD or donation after circulatory death is really a game changer. For decades now, we've been doing heart transplants from donors who die or have been declared brain dead.
There's a whole population of potential donors who have very similar neurologic injuries — they're just not technically declared brain dead — whose organs the family would like to donate.
COMMENTARY
A 'Game Changer' for Heart Transplant: Donation After Circulatory Death Explained
Ileana L. Piña, MD, MPH; Adam D. DeVore, MD, MHS
DisclosuresMarch 24, 2023
Recorded March 4, 2023. This transcript has been edited for clarity.
Ileana L. Piña, MD, MPH: Hello. This is Ileana Piña. I'm at Thomas Jefferson University, and this is my blog.
I am thrilled today to have one of my good friends here with me, Dr Adam DeVore, who's the director of transplant at Duke University. There's been conversation about heart donations, and as most of you know, the hearts are not sitting on the shelf.
When our patients are sick, we really struggle — sometimes for months and maybe even years — to get a heart that is suitable for them, that is the right match, that has the right everything. Hence, many of these patients will die and others will need some kind of circulatory support.
Adam, you have presented on donation after circulatory death (DCD). Define that for us.
Adam D. DeVore, MD, MHS: In the field of heart transplant, DCD or donation after circulatory death is really a game changer. For decades now, we've been doing heart transplants from donors who die or have been declared brain dead.
There's a whole population of potential donors who have very similar neurologic injuries — they're just not technically declared brain dead — whose organs the family would like to donate.
© 2023 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Ileana L. Piña, Adam D. DeVore. A 'Game Changer' for Heart Transplant: Donation After Circulatory Death Explained - Medscape - Mar 24, 2023.
Tables
Authors and Disclosures
Authors and Disclosures
Author(s)
Ileana L. Piña, MD, MPH
Professor of Medicine/Cardiology/Heart Failure/Transplant; Quality Officer, Cardiovascular Line, Sidney Kimmel College of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania; Clinical Professor of Medicine, Central Michigan University College of Medicine, Mount Pleasant, Michigan; Adjunct Professor of Epidemiology and Biostatistics, Population & Quantitative Health Sciences, Case Western University, Cleveland, Ohio
Disclosure: Ileana L. Piña, MD, MPH, has disclosed the following relevant financial relationships:
Serve(d) as a director, office, partner, employee, advisor, consultant, or trustee for: US Food and Drug Administration; Center for Devices and Radiological Health
Adam D. DeVore, MD, MHS
Associate Professor of Medicine, Duke University Medical Center; Medical Director of Cardiac Transplantation, Duke University Hospital, Durham, North Carolina
Disclosure: Adam D. DeVore, MD, MHS, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for:
Abiomed; AstraZeneca; Cardionomic; InnaMed; LivaNova; Natera; Novartis; NovoNordisk; Procyrion; Story Health; Vifor
Serve(d) as a speaker or a member of a speakers bureau for: Biofourmis; Bodyport; Cytokinetics; American Regent, Inc; NHLBI, Novartis; Story Health